CIK: 1262325 - Address: C/O Bridgebio Pharma, Inc., 3160 Porter Dr., Suite 250, Palo Alto, CA 94304
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret1112611550019
P%wins100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

7/8/19 21:29
7/3/19
EIDXEidos Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAguiar EricCADTP26,38329.900882424,576I
5/29/19 19:13
5/24/19
EIDXEidos Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAguiar EricCADTP28,62325.9301,104523,693I
11/21/16 18:29
11/18/16
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesAguiar EricCADP636.28310New10D-10-29-29-25-21-28-29261155

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact